Lenskart Q2 FY27 Revenue Rises 32.5% to ₹2,845 Crore
Key highlights
- Lenskart reported Q2 FY27 consolidated revenue of ₹2,845 crore, up 32.5% year-on-year.
- India revenue rose 35.3% year-on-year to ₹1,668 crore in Q2 FY27.
- India EBITDA pre-Ind AS 116 increased 61.5% to ₹267 crore, with margin reaching 16%.
- India same-store sales growth was 20.8%, while global eye tests rose 40%.
powered by IRIS

Lenskart Solutions Limited reported Q2 FY27 revenue of ₹2,845 crore, a 32.5% year-on-year increase, while profit after tax rose to more than ₹232 crore and India same-store sales growth reached 20.8%. The quarterly figures indicate faster operating growth in its India business alongside higher profitability.
Know Lenskart Solutions inside out
Results, valuation, peers and who's buying, in one view.
What did Lenskart report in Q2 FY27?
Lenskart reported consolidated revenue of ₹2,845 crore for the quarter ended September 30, 2026, up 32.5% from the corresponding quarter a year earlier. The company said EBITDA rose 46.6% year-on-year, while profit after tax crossed ₹232 crore, more than double the prior-year level cited in the earnings-call highlights.
The result was discussed in the Q2 FY27 earnings conference call held on November 4, 2026. Peyush Bansal, Co-Founder and Chief Executive Officer, Abhishek Gupta, Chief Financial Officer, and Vaibhav Sachdeva from investor relations represented the company on the call. The earnings call followed the release of financial results for the quarter and half-year ended September 30, 2026.
The reported revenue increase matters because profit and EBITDA grew faster than the top line. While the supplied earnings highlights do not provide the consolidated EBITDA amount or margin, the 46.6% EBITDA growth exceeded the 32.5% revenue increase. This points to improved operating profitability during the period, based on the company’s reported measures.
How did Lenskart's India business perform?
Lenskart's India revenue rose 35.3% year-on-year to ₹1,668 crore in Q2 FY27, exceeding the reported consolidated revenue growth rate. India revenue for the first half of FY27 reached ₹3,199 crore, representing growth of 33% year-on-year.
India EBITDA before Ind AS 116 was ₹267 crore, up 61.5% year-on-year. The India EBITDA pre-Ind AS 116 margin improved to 16%, compared with 13.4% in the previous year, a rise of 2.6 percentage points. This margin measure excludes the accounting effects associated with Ind AS 116 leases.
Same-store sales growth in India was 20.8%, compared with 14.8% a year earlier. The company also reported 27.1% growth in same-pin-code sales. These metrics show that growth was not confined to newly added locations, as existing-store and local-market sales also increased.
What supported Lenskart's reported growth?
Lenskart linked its quarterly performance to stronger sales in the India business, including a 20.8% increase in same-store sales and 27.1% growth in same-pin-code sales. The higher India EBITDA margin, at 16%, accompanied this revenue growth and was a key feature of the quarterly update.
The company also reported that global eye tests rose 40%. The supplied earnings material does not provide an absolute number for eye tests, regional break-up, or a direct financial contribution from this increase. However, the metric was included in the company’s stated operating highlights alongside revenue and profitability data.
For context, India revenue had increased 30.7% year-on-year to ₹1,531 crore in Q1 FY27. India EBITDA pre-Ind AS 116 margin in that quarter was 15.4%, compared with 13.3% in the prior year. Q2 therefore extended the growth trend reported in the first quarter, with India revenue growth of 35.3% and a 16% margin.
Got a follow-up? Ask IRIS
Why do these results matter for investors?
Lenskart's Q2 FY27 result matters because its India business delivered revenue growth above 35% while its pre-Ind AS 116 EBITDA margin expanded by 2.6 percentage points. Revenue of ₹1,668 crore and EBITDA of ₹267 crore show that the India operation remained the largest specifically disclosed contributor in the supplied results.
For investors, the combination of higher same-store sales and wider operating margin is more informative than revenue growth alone. Same-store sales growth measures performance at comparable outlets, while the margin shows the share of reported revenue retained as pre-Ind AS 116 EBITDA. Both measures improved year-on-year in Q2 FY27.
The earnings material does not disclose a share-price reaction, valuation data, capital expenditure, store additions, or a formal outlook. As a result, the reported numbers establish the quarter’s operating and financial progress but do not support conclusions about market valuation or future earnings beyond the period disclosed.
How does Lenskart's Q2 update fit its recent disclosures?
Lenskart has continued to make earnings-call-related disclosures under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations. The company disclosed an audio recording link for the November 4 call covering the quarter and half-year ended September 30, 2026. It had also disclosed transcripts relating to earlier periods, including the quarter ended June 30, 2026.
The company’s recent disclosures provide a sequence of quarterly updates during FY27. Q1 India revenue was ₹1,531 crore, and Q2 India revenue was ₹1,668 crore. First-half India revenue of ₹3,199 crore is consistent with those two reported quarterly figures and provides the company’s stated half-year measure.
The 40% increase in global eye tests adds an operating indicator beyond sales and margins. But the available source does not state how many tests were performed, the countries involved, or whether the metric will be reported regularly. Those details would be relevant for assessing the scale and consistency of the operating trend.
Conclusion
Lenskart's Q2 FY27 update showed broad-based improvement in reported financial and operating measures. Consolidated revenue rose 32.5% to ₹2,845 crore, India revenue increased 35.3% to ₹1,668 crore, and India EBITDA pre-Ind AS 116 margin improved to 16%. Profit after tax exceeding ₹232 crore added to the evidence of stronger profitability in the quarter.
The next disclosed reference point is the company’s subsequent financial-results update and related earnings call. Investors will watch whether India same-store sales growth, the 16% India EBITDA pre-Ind AS 116 margin, and the reported 40% rise in global eye tests continue in later disclosures, while details on operational expansion or outlook remain undisclosed in the supplied material.


